Literature DB >> 27541141

Depression following acute coronary syndrome: a Danish nationwide study of potential risk factors.

Terese Sara Hoej Joergensen1,2, Solvej Maartensson3,4, Else Helene Ibfelt3, Martin Balslev Joergensen5, Ida Kim Wium-Andersen3,6, Marie Kim Wium-Andersen3,7, Eva Prescott8, Per Kragh Andersen9, Merete Osler3.   

Abstract

PURPOSE: Depression is common following acute coronary syndrome, and thus, it is important to provide knowledge to improve prevention and detection of depression in this patient group. The objectives of this study were to examine: (1) whether indicators of stressors and coping resources were risk factors for developing depression early and later after an acute coronary syndrome and (2) whether prior depression modified these associations.
METHODS: The study was a register-based cohort study, which includes 87,118 patients with a first time diagnosis of acute coronary syndrome during the period 2001-2009 in Denmark. Cox regression models were used to analyse hazard ratios (HRs) for depression.
RESULTS: 1.5 and 9.5 % develop early (≤30 days) and later (31 days-2 years) depression after the acute coronary syndrome. Among all patients with depression, 69.2 % had first onset depression, while 30.8 % developed a recurrent depression. Most patient characteristics (demographic factors, socioeconomic status, psychosocial factors, health-related behavioural factors, somatic comorbidities, and severity of acute coronary syndrome) were significantly associated with increased HRs for both early and later depressions. Prior depression modified most of these associations in such a way that the association was attenuated in patients with a prior depression.
CONCLUSION: Our results indicate that first time and recurrent depression following acute coronary syndrome have different risk profiles. This is important knowledge that may be used to focus future interventions for prevention and detection.

Entities:  

Keywords:  Acute coronary syndrome; Depression; Effect modification; Risk factors

Mesh:

Year:  2016        PMID: 27541141     DOI: 10.1007/s00127-016-1275-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  57 in total

1.  Depression vulnerabilities in patients with different levels of depressive symptoms after acute coronary syndromes.

Authors:  Nina Rieckmann; Matthew M Burg; William Gerin; William F Chaplin; Lynn Clemow; Karina W Davidson
Journal:  Psychother Psychosom       Date:  2006       Impact factor: 17.659

2.  Depressive symptoms and inflammation in patients hospitalized for heart failure.

Authors:  Peter Johansson; Ivonne Lesman-Leegte; Erland Svensson; Adriaan Voors; Dirk J van Veldhuisen; Tiny Jaarsma
Journal:  Am Heart J       Date:  2011-05-11       Impact factor: 4.749

3.  The presence of a depressive episode predicts lower return to work rate after myocardial infarction.

Authors:  Peter de Jonge; Marij Zuidersma; Ute Bültmann
Journal:  Gen Hosp Psychiatry       Date:  2014-03-12       Impact factor: 3.238

4.  Longitudinal course of depressive symptomatology after a cardiac event: effects of gender and cardiac rehabilitation.

Authors:  Sherry L Grace; Susan E Abbey; Ruxandra Pinto; Zachary M Shnek; Jane Irvine; Donna E Stewart
Journal:  Psychosom Med       Date:  2005 Jan-Feb       Impact factor: 4.312

5.  Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events.

Authors:  Peter de Jonge; Rob H S van den Brink; Titia A Spijkerman; Johan Ormel
Journal:  J Am Coll Cardiol       Date:  2006-11-09       Impact factor: 24.094

6.  [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)].

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; W M Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germanò; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvanne; Wilma J M Scholte Op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  G Ital Cardiol (Rome)       Date:  2013-05

7.  Predictors of depressive symptoms post-acute coronary syndrome.

Authors:  Tasneem Z Naqvi; Asim M Rafique; Vonny Andreas; Masoud Rahban; James Mirocha; Syed S A Naqvi
Journal:  Gend Med       Date:  2007-12

Review 8.  Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena.

Authors:  Robert M Post
Journal:  Neurosci Biobehav Rev       Date:  2007-04-24       Impact factor: 8.989

9.  Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients.

Authors:  John C Barefoot; Matthew M Burg; Robert M Carney; Carol E Cornell; Susan M Czajkowski; Kenneth E Freedland; James D Hosking; Parinda Khatri; Carol Rogers Pitula; David Sheps
Journal:  J Cardiopulm Rehabil       Date:  2003 Nov-Dec       Impact factor: 2.081

10.  One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome.

Authors:  Jacqueline J M H Strik; Richel Lousberg; Emile C Cheriex; Adriaan Honig
Journal:  J Psychosom Res       Date:  2004-01       Impact factor: 3.006

View more
  2 in total

1.  Factors associated with emotional distress in patients with myocardial infarction: Results from the SWEDEHEART registry.

Authors:  Fredrika Norlund; Claudia Lissåker; John Wallert; Claes Held; Erik Mg Olsson
Journal:  Eur J Prev Cardiol       Date:  2018-04-25       Impact factor: 7.804

2.  The impact of mental vulnerability on the relationship between cardiovascular disease and depression.

Authors:  Terese Sara Høj Jørgensen; Marie Kim Wium-Andersen; Martin Balslev Jørgensen; Merete Osler
Journal:  Eur Psychiatry       Date:  2020-02-14       Impact factor: 5.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.